NeSPaT

NeSPaT competes in a category most buyers don’t know is a category. Sponsors and CROs need patient logistics — travel, reimbursement, sample handling — but the market has historically treated it as one-off coordination, handled by internal teams or general travel agencies. The dedicated clinical trial participant logistics category is real, growing, and undersearched.

The checkable facts

Read September 24, 2026 from NeSPaT's own sites.

Fact	What NeSPaT says	Source
What it does	“NeSPaT provides end-to-end patient logistics management tailored specifically for clinical trials” and “NeSPaT exclusively supports travel for clinical trials”	nespat.com
Reach	“operating in 50+ countries across all continents”	Services
Reimbursement	“Once a complete order is received, payments are guaranteed within 2 business days”	Services
Brand origin	“In 2013, we received our first orders for organizing patient transportation. In 2017, we created the separate brand 'NeSPaT' as an acronym for New Standard of Patient Travel”	About
Parent company	“Since 2004, the parent company 'New Standard of Business Travel' has been organizing corporate events and business travel”	About

Two of those rows correct things a buyer would otherwise get wrong. Two business days is not forty-eight hours — across a weekend it is materially longer, and the clock starts from a complete order, not from the participant's visit. And 2017 is the brand, not the company: patient transport work started in 2013 and the parent has been in corporate travel since 2004, which is the number that actually speaks to operational depth.

The services list is also wider than travel: home nursing, direct-to-patient delivery, stipend payments and investigator meetings sit alongside transfers, accommodation and biomaterial sample logistics.

What a sponsor should check

Participant logistics vendors are bought on two axes that have nothing to do with each other. The first is reach — whether the vendor can actually service every site in your protocol, including the one country that makes the map hard. The second is fair-market-value compliance, because participant payments and travel benefits are regulated and an undisciplined reimbursement flow creates an inducement problem, not a retention win.

Ask for the country list against your own site list, and ask how reimbursement is documented, not how fast it is.

Why this category

AuthorityTech is NeSPaT's earned-media agency. The work is to install the category language itself: Healthcare Business Today reaches the operations-and-compliance reader who actually evaluates patient-services vendors, framing NeSPaT as the specialist when participant retention and FMV compliance both matter.

Every figure above is dated and attributed to the NeSPaT page that published it. NeSPaT describes itself as “a leading provider of participant services for clinical trials”; that is the company's own characterisation, and this page does not repeat it as an established fact.